Adiponectin may decrease T2DM risk via a number of mechanisms including hepatic fatty acid oxidation, enhanced peripheral glucose uptake, and stimulated insulin secretion [16]. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.